CDXS
Price
$2.44
Change
+$0.05 (+2.09%)
Updated
Jun 30 closing price
Capitalization
202.14M
30 days until earnings call
MGX
Price
$1.48
Change
+$0.02 (+1.37%)
Updated
Jun 30 closing price
Capitalization
55.14M
43 days until earnings call
Interact to see
Advertisement

CDXS vs MGX

Header iconCDXS vs MGX Comparison
Open Charts CDXS vs MGXBanner chart's image
Codexis
Price$2.44
Change+$0.05 (+2.09%)
Volume$652.72K
Capitalization202.14M
Metagenomi
Price$1.48
Change+$0.02 (+1.37%)
Volume$250.1K
Capitalization55.14M
CDXS vs MGX Comparison Chart in %
Loading...
CDXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CDXS vs. MGX commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDXS is a StrongBuy and MGX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 01, 2025
Stock price -- (CDXS: $2.44 vs. MGX: $1.48)
Brand notoriety: CDXS and MGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CDXS: 77% vs. MGX: 53%
Market capitalization -- CDXS: $202.14M vs. MGX: $55.14M
CDXS [@Biotechnology] is valued at $202.14M. MGX’s [@Biotechnology] market capitalization is $55.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CDXS’s FA Score shows that 0 FA rating(s) are green whileMGX’s FA Score has 1 green FA rating(s).

  • CDXS’s FA Score: 0 green, 5 red.
  • MGX’s FA Score: 1 green, 4 red.
According to our system of comparison, both CDXS and MGX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CDXS’s TA Score shows that 5 TA indicator(s) are bullish while MGX’s TA Score has 5 bullish TA indicator(s).

  • CDXS’s TA Score: 5 bullish, 3 bearish.
  • MGX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, CDXS is a better buy in the short-term than MGX.

Price Growth

CDXS (@Biotechnology) experienced а +3.39% price change this week, while MGX (@Biotechnology) price change was +4.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.71%. For the same industry, the average monthly price growth was +31.92%, and the average quarterly price growth was +6.10%.

Reported Earning Dates

CDXS is expected to report earnings on Jul 31, 2025.

MGX is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+3.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CDXS($202M) has a higher market cap than MGX($55.1M). CDXS YTD gains are higher at: -48.847 vs. MGX (-59.003). CDXS has higher annual earnings (EBITDA): -62.28M vs. MGX (-82.2M). MGX has more cash in the bank: 226M vs. CDXS (59.8M). MGX has less debt than CDXS: MGX (44.4M) vs CDXS (59.5M). CDXS has higher revenues than MGX: CDXS (49.8M) vs MGX (45.3M).
CDXSMGXCDXS / MGX
Capitalization202M55.1M367%
EBITDA-62.28M-82.2M76%
Gain YTD-48.847-59.00383%
P/E RatioN/AN/A-
Revenue49.8M45.3M110%
Total Cash59.8M226M26%
Total Debt59.5M44.4M134%
FUNDAMENTALS RATINGS
CDXS: Fundamental Ratings
CDXS
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
86
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CDXSMGX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
70%
MACD
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
84%
Bullish Trend 6 days ago
79%
Declines
ODDS (%)
Bearish Trend 19 days ago
84%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
85%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CDXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HRCCX29.51N/A
N/A
Carillon ClariVest Capital Apprec C
GOGFX39.33N/A
N/A
Victory Sycamore Small Company Opp R
VARCX10.78N/A
N/A
First Trust Merger Arbitrage Cl C
POIRX16.43N/A
N/A
Polen International Growth Investor
VIKSX11.25N/A
N/A
Virtus KAR Small-Mid Cap Growth I

CDXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDXS has been loosely correlated with BEAM. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if CDXS jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDXS
1D Price
Change %
CDXS100%
+2.09%
BEAM - CDXS
49%
Loosely correlated
+1.25%
PRAX - CDXS
49%
Loosely correlated
-2.21%
DNLI - CDXS
49%
Loosely correlated
-0.78%
CRSP - CDXS
48%
Loosely correlated
+4.15%
NTLA - CDXS
47%
Loosely correlated
-1.88%
More

MGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGX has been loosely correlated with KOD. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if MGX jumps, then KOD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGX
1D Price
Change %
MGX100%
+1.37%
KOD - MGX
42%
Loosely correlated
+1.08%
KYTX - MGX
35%
Loosely correlated
-6.40%
SABS - MGX
34%
Loosely correlated
+3.85%
CVM - MGX
33%
Loosely correlated
-4.58%
CDXS - MGX
33%
Poorly correlated
+2.09%
More